Nestle is debuting a new infant formula containing a proprietary blend in Hong Kong in November 2023. The blend is said to be an “all-round” nutrition for supporting multiple growth areas, including digestive, bone, and cognitive health.
Taiwan Food and Drug Administration (FDA) is considering the use of 2’-fucosyllactose (2’-FL) fermented from two new microbial strains in all infant and toddler food products, including Foods for Special Medical Purposes (FSMPs).
